1.. Introduction {#sec1}
================

*Shigella flexneri*, the causative agent of shigellosis, is a Gram-negative bacterial pathogen that initiates infection by invading cells of the colonic epithelium in a process which is dependent on a type III secretion system (T3SS; Phalipon & Sansonetti, 2003[@bb19]). The T3SS is composed of a basal body, which traverses both bacterial membranes, and an external needle through which effector proteins are secreted (Blocker *et al.*, 2001[@bb2]). During *S. flexneri* infection, secretion is activated by contact of the tip of the needle complex with host cells, resulting in formation of a pore in the host-cell membrane that is contiguous with the needle. Other effector proteins are injected *via* this apparatus directly into the host-cell cytoplasm (for a review, see Johnson *et al.*, 2005[@bb13]).

Of the T3SS effectors, IpaB, IpaC and IpaD are essential for invasion (Menard *et al.*, 1993[@bb17]). IpaB and IpaC have been demonstrated to insert into the host-cell membrane and are therefore suggested to form the translocation pore (Blocker *et al.*, 1999[@bb1]). Cells lacking IpaD are not only incapable of pore insertion and invasion, but also demonstrate impaired effector secretion control (Picking *et al.*, 2005[@bb20]). IpaD was originally proposed to form a plug in the T3SS with IpaB (Menard *et al.*, 1994[@bb16]), but more recent data has demonstrated that its role is more complex (Picking *et al.*, 2005[@bb20]). Deletions within the N-terminal third of the molecule do not affect invasion of the bacteria into host cells, although the insertion of IpaB/IpaC into membranes is slightly impaired. However, even short deletions (five residues) in the C-terminus of IpaD completely abolish the invasive phenotype and pore insertion. These observations, combined with the functional homology between IpaD and LcrV, a protein recently shown to be assembled at the tip of the *Yersinia pestis* T3SS needle (Mueller *et al.*, 2005[@bb18]), suggest that IpaD may play a role in regulating insertion of the IpaB/IpaC translocon pore from the tip of the *S. flexneri* needle.

Our laboratory has recently determined the crystal structure of MxiH, the needle subunit, and assembled a molecular model of the T3SS needle by docking it into a 16 Å EM reconstruction of the *S. flexneri* needle (Cordes *et al.*, 2003[@bb4]; Deane, Cordes *et al.*, 2006[@bb5]; Deane, Roversi *et al.*, 2006[@bb6]). As part of an ongoing study into the interactions of the T3SS with host cells, we have now expressed, purified and crystallized IpaD. The three-dimensional structure of IpaD, in conjunction with the structure of the MxiH needle and other tip proteins such as LcrV (Derewenda *et al.*, 2004[@bb7]), will hopefully allow us to delineate the mechanism of translocon insertion.

2.. Experimental procedures {#sec2}
===========================

2.1.. Expression and purification {#sec2.1}
---------------------------------

The DNA fragment of the *ipaD* gene encoding residues 15--332 was produced using the methods described previously (Harrington *et al.*, 2003[@bb11]; Picking *et al.*, 2005[@bb20]) and subcloned into the pET-15b vector. This construct placed the gene in frame with an N-terminal hexahistidine tag. IpaD~NΔ14~ was expressed in *Escherichia coli* BL21 (DE3) cells grown in LB media containing 100 µg ml^−1^ ampicillin. Cells were grown at 310 K to an *A* ~600nm~ of 0.6 and protein overexpression was induced by the addition of 1.0 m*M* IPTG. After 3 h, cells were harvested by centrifugation (4000*g*, 15 min, 277 K) and pellets were frozen at 193 K. Cell pellets were resuspended in lysis buffer \[20 m*M* Tris--HCl pH 7.5, 500 m*M* NaCl and Complete EDTA-free protease inhibitor cocktail (Roche)\] and lysed using an Emulsiflex-C5 Homogeniser (Glen Creston, UK). The resultant cell suspension was centrifuged (20 000*g*, 30 min, 277 K) and the soluble fraction was applied onto a pre-charged 5 ml His-Trap HP nickel-affinity column (Amersham Biosciences). Protein was eluted using a gradient of 0--­1 *M* imidazole in lysis buffer. Fractions containing IpaD~NΔ14~ were further purified by gel-filtration chromatography using a HiLoad 26/60 Superdex 75 column (Amersham Biosciences) equilibrated in 20 m*M* Tris--HCl pH 7.5, 100 m*M* NaCl, 10 m*M* DTT. IpaD~NΔ14~ eluted as a single monomeric peak and was demonstrated to be pure by SDS--PAGE; mass-spectrometric analysis (data not shown) confirmed the molecular weight of the protein minus the N-terminal methionine (37 374 Da). Fractions containing purified IpaD~NΔ14~ were pooled, concentrated using 5 kDa molecular-weight VivaSpin centrifugal concentrators (VivaScience, Sartorius Group) to approximately 70 mg ml^−1^ and stored at 193 K in 50 µl aliquots.

SeMet-labelled IpaD~NΔ14~ was produced by expression in the *E. coli met* ^*−*^ auxotrophic strain B834 (DE3). Cultures were grown in LB media to an *A* ~600nm~ of 0.2, pelleted (4000*g*, 15 min, 277 K) and washed in phosphate-buffered saline three times. Washed cells were used to inoculate SelenoMet Medium Base containing SelenoMet Nutrient Mix, [l]{.smallcaps}-selenomethionine (40 µg ml^−1^; Molecular Dimensions Ltd, UK) and ampicillin (100 µg ml^−1^). Cultures were grown at 310 K until an *A* ~600nm~ of 0.6 was reached, whereupon the solutions were cooled to 293 K and protein overexpression was induced by the addition of 1.0 m*M* IPTG. After 16 h, cells were harvested and SeMet-labelled protein was purified as described above. Mass-spectrometric analysis confirmed full incorporation of SeMet, including the N-terminal methionine (data not shown), in contrast to the native protein. We assume this is a consequence of the incorporation of the selenium making the N-terminal peptide bond less likely to be cleaved.

2.2.. Crystallization and limited proteolysis {#sec2.2}
---------------------------------------------

Initial crystallization conditions were obtained by sparse-matrix screening (Jancarik & Kim, 1991[@bb12]) using the sitting-drop vapour-diffusion technique. Drops were prepared by mixing 0.2 µl protein solution (70 mg ml^−1^, 20 m*M* Tris--HCl pH 7.5, 100 m*M* NaCl, 10 m*M* DTT) with 0.2 µl reservoir solution using a Tecan crystallization robot (Tecan UK, Theale, UK) and were equilibrated against 100 µl reservoir solution at 293 K. Initial crystals of IpaD~NΔ14~ (crystal form 1) grew in 3 d in condition No. 33 of Molecular Dimensions Screen 1 \[30%(*w*/*v*) PEG 4000, 0.1 *M* Tris--HCl pH 8.5, 0.2 *M* MgCl~2~\]. Subsequent screening using handmade conditions yielded diffraction-quality crystals in PEG 4000 concentrations ranging from 25 to 28%(*w*/*v*). Mercury derivatives were prepared by adding 1 µl of 10 m*M* HgCl~2~ in reservoir solution to the 0.4 µl drop. Crystals were soaked for 3 h at 293 K.

One IpaD~NΔ14~ crystal form (crystal form 2) grew over a period of 12 months in 10%(*v*/*v*) PEG 400, 0.1 *M* NaCl, 0.1 *M* Tris--HCl pH 7.0 (Fig. 1[▶](#fig1){ref-type="fig"} *a*) and was discovered to be an N-terminal truncation of IpaD~NΔ14~. In an attempt to reproduce this and find new crystal forms, in-drop limited proteolysis was carried out (as in Gaur *et al.*, 2004[@bb10]). The broad-spectrum serine protease subtilisin Carlsberg from *Bacillus licheniformis* (Sigma--Aldrich) was added to IpaD~NΔ14~ in a 1:5000 enzyme:protein ratio by weight before sparse-matrix screening was carried out as described above. Diffraction-quality native crystals were obtained in Molecular Dimensions Screen 1 condition No. 24 \[30%(*v*/*v*) PEG 400, 0.1 *M* Na HEPES pH 7.5, 0.2 *M* MgCl~2~\] (crystal form 3) and Molecular Dimensions Screen 2 condition No. 19 \[10%(*w*/*v*) PEG 8000, 0.1 *M* Na HEPES pH 7.5, 8%(*v*/*v*) ethylene glycol\] (crystal form 4A; Fig. 1[▶](#fig1){ref-type="fig"} *b*). Diffraction-quality SeMet crystals were obtained in Molecular Dimensions Screen 1 condition No. 23 \[28%(*v*/*v*) PEG 400, 0.1 *M* Na HEPES pH 7.5, 0.2 *M* CaCl~2~\] (crystal form 5) and Molecular Dimensions Screen 1 condition No. 34 \[30%(*v*/*v*) PEG 400, 0.1 *M* Tris--HCl pH 8.5, 0.2 *M* sodium citrate\] (crystal form 4B). Numerous other conditions in Molecular Dimensions Screens 1 and 2 yielded crystals that were too small to collect data from.

2.3.. Data collection and processing {#sec2.3}
------------------------------------

Crystal forms 1, 2, 3, 4A and 5 were cryoprotected in reservoir solution containing 20%(*v*/*v*) glycerol, 20%(*v*/*v*) PEG 400, 5%(*v*/*v*) PEG 400, 25%(*v*/*v*) ethylene glycol and 5%(*v*/*v*) PEG 400, respectively, and flash-cryocooled in liquid nitrogen prior to data collection. Crystal form 4B was mounted and flash-cryocooled directly in the cryostream.

Diffraction data were recorded at 100 K (Table 1[▶](#table1){ref-type="table"}). Data were indexed and integrated in *MOSFLM* (Leslie, 1992[@bb14]) and scaled with *SCALA* (Evans, 1997[@bb9]) within the *CCP*4 program suite (Collaborative Computational Project, Number 4, 1994[@bb3]). A fluorescence scan on a SeMet crystal (CF-4B) across the Se edge yielded values of = −8.0 and = 5.2 using the program *CHOOCH* (Evans & Pettifer, 2001[@bb8]).

3.. Results and discussion {#sec3}
==========================

Intact IpaD~NΔ14~ yielded plate-shaped crystals (CF-1) belonging to space group *P*2~1~2~1~2~1~ (Table 1[▶](#table1){ref-type="table"}). Calculation of a native Patterson map revealed a peak at ∼50% of the origin on Harker section *v* = 0.5, consistent with two molecules per asymmetric unit related by a pure translation (Fig. 2[▶](#fig2){ref-type="fig"}). The value of the Matthews coefficient is 2.1 Å^3^ Da^−1^ for two molecules, corresponding to a solvent content of 42% (Matthews, 1968[@bb15]). Attempts to grow diffraction-quality SeMet crystals in this crystal form were unsuccessful. Soaking the crystals with mercury increased the quality of diffraction of the crystals but did not yield a reliable set of Hg sites, despite using the available Patterson-solving software.

During optimization of CF-1 a second crystal form was observed (CF-2) which took 12 months to grow and belongs to space group *C*2 (Fig. 1[▶](#fig1){ref-type="fig"}). One crystal was used for data collection and the remainder were re-solubilized, run on SDS--PAGE and N-terminal sequenced. This revealed a major band corresponding to an N-terminal truncation beginning at residue 144 (data not shown). The value of the Matthews coefficient is 2.4 Å^3^ Da^−1^ for two molecules, corresponding to 49% solvent content.

The contents of CF-2 revealed that the N-terminal third of IpaD is susceptible to degradation and suggested that limited proteolysis could trim these regions. In an attempt to reproduce CF-2 and search for new crystal forms, the broad-spectrum protease subtilisin Carlsberg was added in trace amounts to IpaD~NΔ14~ before screening. Plate-shaped crystals were grown in three new crystal forms (CF-3, CF-4 and CF-5; Table 1[▶](#table1){ref-type="table"}) and analysis by SDS--PAGE revealed various degrees of N-terminal truncation (Fig. 1*b* [▶](#fig1){ref-type="fig"}). The value of the Matthews coefficient is 2.1 and 2.5 Å^3^ Da^−1^ for CF-3 and CF-4, respectively, for two molecules per asymmetric unit and is 2.6 Å^3^ Da^−1^ in CF-5 for four molecules.

Anomalous difference Patterson maps for SeMet derivatives of CF-4 were calculated within *autoSHARP* (Vonrhein *et al.*, 2005[@bb21]) using (*E* ^2^ − 1) coefficients and strict outlier rejection. The positions of ten Se atoms were obtained using the Patterson-solving software within *autoSHARP* and were refined using *SHARP*. The ten sites clustered into two sets of five related by the twofold peak in the self-rotation function (Fig. 3[▶](#fig3){ref-type="fig"}). Structure determination and refinement in the various crystal forms is under way.
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![(*a*) Monoclinic crystals of IpaD crystal form 2 produced by in-drop proteolysis. (*b*) SDS--PAGE of protein derived from crystals with (CF-3 and CF-5) and without (CF-1) subtilisin treatment (see text for full description). The subscript denotes the portion of IpaD present in each band as determined by sequencing (FL, full length; Δ120, N-terminal deletion to residue 120). Molecular-weight markers are shown in lane 2; the marker identified with 'M' corresponds to a MW of 42 kDa.](f-62-00865-fig1){#fig1}

![Harker section *v* = 0.5 of the native Patterson map of IpaD crystal form 1 calculated using *PATTERSON* (Collaborative Computational Project, Number 4, 1994[@bb3]) at 3.5 Å. The map is drawn with a minimum contour level of 1.5σ with 0.5σ increments.](f-62-00865-fig2){#fig2}

![The *κ* = 180° section of the self-rotation function calculated for the crystal form 4 SeMet peak 1 data set using *MOLREP* (Collaborative Computational Project, Number 4, 1994[@bb3]) with an integration radius of 20.0 Å and data in the resolution range 15--4 Å. The peak (marked with an X) at (ω, ϕ) = (22, 0°) represents 91% of the peak for the crystallographic twofold axis.](f-62-00865-fig3){#fig3}

###### IpaD X-ray diffraction data-collection statistics

Values in parentheses are for the highest resolution shells.

                                              CF-1                 CF-2                 CF-3                 CF-4A                CF-4B SeMet MAD      CF-5                                                                                
  ------------------------------------------- -------------------- -------------------- -------------------- -------------------- -------------------- -------------------- -------------------- -------------------- -------------------- --------------------
  X-ray source                                ESRF, ID14-3         ESRF, ID23-1         ESRF, ID14-1         ESRF, ID23-2         ESRF, ID23-1         ESRF, ID23-1         ESRF, BM16                                                     
  Detector                                    MAR CCD              MAR CCD              ADSC scanner         MAR CCD              ADSC scanner         ADSC scanner         MAR CCD                                                        
  Space group                                 *P*2~1~2~1~2~1~      *P*2~1~2~1~2~1~      *C*2                 *C*2                 *C*2                 *C*2                 *P*2~1~                                                        
  Unit-cell parameters                                                                                                                                                                                                                     
    *a* (Å)                                   55.9                 56.2                 77.9                 204.6                139.4                136.9                44.9                                                           
    *b* (Å)                                   100.7                102.4                91.5                 45.1                 45.0                 44.3                 205.9                                                          
    *c* (Å)                                   112.0                111.5                54.9                 56.8                 99.5                 100.0                110.9                                                          
   β (°)                                                                                96.4                 105.2                107.9                107.4                102.5                                                          
  Wavelength (Å)                              0.931                1.0055               0.934                0.873                0.9757               0.9792               0.9792               0.9792               0.9757               0.9790
  Resolution limits (Å)                       75--2.7 (2.8--2.7)   38--3.2 (3.4--3.2)   42--2.0 (2.1--2.0)   30--3.5 (3.7--3.5)   43--2.8 (3.0--2.8)   34--3.4 (3.6--3.4)   34--3.4 (3.6--3.4)   34--3.2 (3.4--3.2)   48--3.3 (3.5--3.3)   41--3.9 (4.1--3.9)
  Completeness (%)                            90.1 (68.2)          99.9 (100.0)         99.2 (99.8)          96.5 (96.5)          99.0 (96.3)          99.2 (96.4)          99.4 (96.7)          99.5 (100.0)         97.8 (87.5)          86.4 (86.7)
  Unique reflections                          14594                11143                24238                5840                 14425                7938                 8009                 9703                 8518                 7495
  Multiplicity                                7.0 (3.0)            7.8 (7.9)            3.0 (3.0)            4.6 (4.7)            5.2 (4.6)            6.9 (6.6)            7.0 (6.8)            3.6 (3.7)            6.8 (6.2)            8.8 (8.2)
  *R*~merge~[†](#tfn1){ref-type="table-fn"}   14.1 (48.2)          14.0 (37.2)          5.3 (41.8)           13.2 (41.6)          11.5 (29.2)          9.6 (33.6)           8.4 (23.1)           11.0 (33.5)          8.9 (25.8)           22.7 (42.1)
  *I*/σ(*I*)                                  3.9 (1.6)            3.8 (1.8)            7.9 (1.7)            3.0 (1.5)            3.1 (1.9)            5.6 (2.2)            5.6 (3.0)            4.5 (2.0)            5.9 (2.7)            2.6 (1.7)
  *R*~anom~[‡](#tfn2){ref-type="table-fn"}    ---                  ---                  ---                  ---                  ---                  6.7 (15.0)           5.5 (9.0)            5.4 (11.4)           4.0 (10.8)           ---

*R* ~merge~ = 100 × , where *I*(*h*)*~i~* is the *i*th observation of reflection *h* and 〈*I*(*h*)〉 is the mean intensity of all observations of *h*.

*R* ~anom~ = 100 × , where 〈*I^+^*〉 and 〈*I^−^*〉 are the mean intensities of the Bijvoet pairs for observation *h*.
